Дніпропетровська медична академія | Dnipropetrovsk Medical Academy | ДМА
Дніпропетровська медична академія | Dnipropetrovsk Medical Academy | ДМА
Державний заклад "Дніпропетровська медична академія Міністерства охорони здоров'я України"
Verified email at dma.dp.ua - Homepage
TitleCited byYear
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
C Robert, L Thomas, I Bondarenko, S O’Day, J Weber, C Garbe, ...
N Engl J Med, 2517-2526, 2011
40202011
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
C Bokemeyer, I Bondarenko, A Makhson, JT Hartmann, J Aparicio, ...
JOURNAL OF CLINICAL ONCOLOGY| 10th World Congress on Gastrointestinal …, 2009
18562009
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ...
New England Journal of Medicine 354 (14), 1464-1476, 2006
12912006
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptorpositive, HER2-negative …
The lancet oncology 16 (1), 25-35, 2015
12192015
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
GV Long, D Stroyakovskiy, H Gogas, E Levchenko, F de Braud, J Larkin, ...
NEW ENGLAND JOURNAL OF MEDICINE 371 (20), 1877-1888, 2014
11782014
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non–small-cell lung cancer: results from a randomized, double-blind …
TJ Lynch, I Bondarenko, A Luft, P Serwatowski, F Barlesi, R Chacko, ...
Journal of clinical oncology 30 (17), 2046-2054, 2012
9162012
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor …
NJ Robert, V Dieras, J Glaspy, AM Brufsky, I Bondarenko, ON Lipatov, ...
JOURNAL OF CLINICAL ONCOLOGY 29 (10), 1252-1260, 2011
8902011
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
GV Long, D Stroyakovskiy, H Gogas, E Levchenko, F de Braud, J Larkin, ...
LANCET 386 (9992), 444-451, 2015
8432015
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial
SS Hassan, R Romero, D Vidyadhari, S Fusey, JK Baxter, M Khandelwal, ...
ULTRASOUND IN OBSTETRICS & GYNECOLOGY 38 (1), 18-31, 2011
7852011
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
C Bokemeyer, I Bondarenko, JT Hartmann, F de Braud, G Schuch, ...
ANNALS OF ONCOLOGY 22 (7), 1535-1546, 2011
7502011
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous …
M Cristofanilli, NC Turner, I Bondarenko, J Ro, SA Im, N Masuda, ...
LANCET ONCOLOGY 17 (4), 425-439, 2016
7222016
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised …
M Reck, R Kaiser, A Mellemgaard, JY Douillard, S Orlov, M Krzakowski, ...
LANCET ONCOLOGY 15 (2), 143-155, 2014
6712014
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer
A Di Leo, G Jerusalem, L Petruzelka, R Torres, IN Bondarenko, ...
J Clin Oncol 28 (30), 4594-4600, 2010
5682010
Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung …
MA Socinski, I Bondarenko, NA Karaseva, AM Makhson, I Vynnychenko, ...
J Clin Oncol 30 (17), 2055-2062, 2012
5542012
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
SJ O'Day, M Maio, V Chiarion-Sileni, TF Gajewski, H Pehamberger, ...
ANNALS OF ONCOLOGY 21 (8), 1712-1717, 2010
4922010
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind …
M Reck, I Bondarenko, A Luft, P Serwatowski, F Barlesi, R Chacko, ...
ANNALS OF ONCOLOGY 24 (1), 75-83, 2013
4802013
Компьютерная зависимость: формирование, диагностика, коррекция и профилактика
ЛН Юрьева, ТЮ Больбот
Пороги, 2006
4602006
Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
M Maio, JJ Grob, S Aamdal, I Bondarenko, C Robert, L Thomas, C Garbe, ...
JOURNAL OF CLINICAL ONCOLOGY 33 (10), 1191-1196, 2015
3662015
Профессиональное выгорание у медицинских работников
ЛН Юрьева
Сфера, 2004
3092004
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
BI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...
New England Journal of Medicine 380 (12), 1116-1127, 2019
3012019
The system can't perform the operation now. Try again later.
Articles 1–20